Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > Biologics Outsourcing Market

Biologics Outsourcing Market Share

Report ID: GMI6621
Published Date: Sep 2023
Report Format: PDF

Download Free Sample

Biologics outsourcing Market Share

Major market players operating in the biologics outsourcing market include:

AbbVie Inc
Thermo Fisher Scientific
Boehringer Ingelheim
International GmbH
Merck & Co.,
Lonza Group AG
Catalent Inc

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Biologics outsourcing market size was valued at USD 20.5 billion in 2022 and will reach USD 75 billion by 2032 due to the growing pipeline of biologic drugs, particularly in the fields of oncology, autoimmune disorders, and infectious diseases worldwide.

The antibodies product segment recorded 60.9% share in the industry in 2022 and will witness significant growth from 2023-2032 on account of rising application in the treatment of cancer, autoimmune diseases, and infectious diseases.

North America held 46.3% share in the industry in 2022 and is expected to register 12.2% CAGR from 2023-2032 owing to the robust healthcare infrastructure and the strong emphasis on innovations in the region.

AbbVie Inc., Thermo Fisher Scientific, Inc., Boehringer Ingelheim, International GmbH, Merck & Co., Inc., Lonza Group AG, and Catalent Inc. are some of the major biologics outsourcing companies worldwide.